Published Date：Mar.2021
Industry：Pharma & Healthcare
Pages：101 Table Number：126
Single User Price：￥3650.00
Enterprise User Price：￥5600.00
Summary As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%. Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States. In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter. Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970. Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Regenerative Drugs market in this environment. In terms of revenue, this research report indicated that the global Regenerative Drugs market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Regenerative Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments. The Stryker aims at producing XX K Units Regenerative Drugs in 2020, with XX % production to take place in global market, Zimmer Biomet Holdings accounts for a volume share of XX %. Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Regenerative Drugs Market by XYZResearch Include China EU USA Japan India Southeast Asia South America Competitive Analysis; Who are the Major Players in Regenerative Drugs Market? Stryker Zimmer Biomet Holdings Medtronic Athersys STEMCELL Technologies Organogenesis Integra Lifesciences Acelity Isto Biologics CryoLife ... Major Type of Regenerative Drugs Covered in XYZResearch report: Synthetic Material Biologically Derived Material Others Application Segments Covered in XYZResearch Market Cardiovascular Dermatology Musculoskeletal Neurology Others For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents Global Regenerative Drugs Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate 1 Market Scope 1.1 Product Details and Introduction 1.1.1 Synthetic Material -Product Introduction and Major Manufacturers 1.1.2 Biologically Derived Material -Product Introduction and Major Manufacturers 1.1.3 Others -Product Introduction and Major Manufacturers 1.2 Market Snapshot 1.2.1 Major Companies Overview 1.2.2 Market Concentration 1.2.3 Six-Year Compound Annual Growth Rate (CAGR) 2 Global Regenerative Drugs Market Assessment, by Segmentation 2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027) 2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027) 2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027) 3 Regional Market Analysis 3.1 China Regenerative Drugs Market 3.1.1 Top Companies leading Regenerative Drugs Development in China (2016-2021) 3.1.2 Sales Value of Major Company in China Market (2016-2021) 3.1.3 China Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.1.4 Sales in China Market, by Type (2026-2027) 3.2 EU Regenerative Drugs Market 3.2.1 Top Companies leading Regenerative Drugs Development in EU (2016-2021) 3.2.2 Sales Value of Major Company in EU Market (2016-2021) 3.2.3 EU Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.2.4 Sales in EU Market, by Type (2026-2027) 3.3 USA Regenerative Drugs Market 3.3.1 Top Companies leading Regenerative Drugs Development in USA (2016-2021) 3.3.2 Sales Value of Major Company in USA Market (2016-2021) 3.3.3 USA Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.3.4 Sales in USA Market, by Type (2026-2027) 3.4 Japan Regenerative Drugs Market 3.4.1 Top Companies leading Regenerative Drugs Development in Japan (2016-2021) 3.4.2 Sales Value of Major Company in Japan Market (2016-2021) 3.4.3 Japan Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.4.4 Sales in Japan Market, by Type (2026-2027) 3.5 India Regenerative Drugs Market 3.5.1 Top Companies leading Regenerative Drugs Development in India (2016-2021) 3.5.2 Sales Value of Major Company in India Market (2016-2021) 3.5.3 India Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.5.4 Sales in India Market, by Type (2026-2027) 3.6 Southeast Asia Regenerative Drugs Market 3.6.1 Top Companies leading Regenerative Drugs Development in Southeast Asia (2016-2021) 3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021) 3.6.3 Southeast Asia Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.6.4 Sales in Southeast Asia Market, by Type (2026-2027) 3.7 South America Regenerative Drugs Market 3.7.1 Top Companies leading Regenerative Drugs Development in South America (2016-2021) 3.7.2 Sales Value of Major Company in South America Market (2016-2021) 3.7.3 South America Regenerative Drugs Price (USD/Unit), by Type (2019-2020) 3.7.4 Sales in South America Market, by Type (2026-2027) 4 Value Chain (Impact of COVID-19) 4.1 Regenerative Drugs Value Chain Analysis 4.1.1 Upstream 4.1.2 Downstream 4.2 COVID-19 Impact on Regenerative Drugs Industry 4.2.1 Industrial Policy Issued Under the Epidemic Situation 4.3 Cost-Under the Epidemic Situation 4.3.1 Cost of Raw Material 4.4 Channel Analysis 4.4.1 Distribution Channel-Under the Epidemic Situation 4.4.2 Distributors 5 Regional Market Forecast (2021-2027) 5.1 Global Regenerative Drugs Sales and Growth Rate (2021-2027) 5.2 Global Regenerative Drugs Sales Value and Growth Rate (2021-2027) 6 Regenerative Drugs Competitive Analysis 6.1 Stryker 6.1.1 Stryker Company Profiles 6.1.2 Stryker Product Introduction 6.1.3 Stryker Regenerative Drugs Production, Revenue (2016-2021) 6.1.4 SWOT Analysis 6.2 Zimmer Biomet Holdings 6.2.1 Zimmer Biomet Holdings Company Profiles 6.2.2 Zimmer Biomet Holdings Product Introduction 6.2.3 Zimmer Biomet Holdings Regenerative Drugs Production, Revenue (2016-2021) 6.2.4 SWOT Analysis 6.3 Medtronic 6.3.1 Medtronic Company Profiles 6.3.2 Medtronic Product Introduction 6.3.3 Medtronic Regenerative Drugs Production, Revenue (2016-2021) 6.3.4 SWOT Analysis 6.4 Athersys 6.4.1 Athersys Company Profiles 6.4.2 Athersys Product Introduction 6.4.3 Athersys Regenerative Drugs Production, Revenue (2016-2021) 6.4.4 SWOT Analysis 6.5 STEMCELL Technologies 6.5.1 STEMCELL Technologies Company Profiles 6.5.2 STEMCELL Technologies Product Introduction 6.5.3 STEMCELL Technologies Regenerative Drugs Production, Revenue (2016-2021) 6.5.4 SWOT Analysis 6.6 Organogenesis 6.6.1 Organogenesis Company Profiles 6.6.2 Organogenesis Product Introduction 6.6.3 Organogenesis Regenerative Drugs Production, Revenue (2016-2021) 6.6.4 SWOT Analysis 6.7 Integra Lifesciences 6.7.1 Integra Lifesciences Company Profiles 6.7.2 Integra Lifesciences Product Introduction 6.7.3 Integra Lifesciences Regenerative Drugs Production, Revenue (2016-2021) 6.7.4 SWOT Analysis 6.8 Acelity 6.8.1 Acelity Company Profiles 6.8.2 Acelity Product Introduction 6.8.3 Acelity Regenerative Drugs Production, Revenue (2016-2021) 6.8.4 SWOT Analysis 6.9 Isto Biologics 6.9.1 Isto Biologics Company Profiles 6.9.2 Isto Biologics Product Introduction 6.9.3 Isto Biologics Regenerative Drugs Production, Revenue (2016-2021) 6.9.4 SWOT Analysis 6.10 CryoLife 6.10.1 CryoLife Company Profiles 6.10.2 CryoLife Product Introduction 6.10.3 CryoLife Regenerative Drugs Production, Revenue (2016-2021) 6.10.4 SWOT Analysis 7 Conclusion
List of Tables and Figures Figure Product Introduction Table Production (K Units) and Revenue (Million USD) of Major Players (2016-2021) Figure Global Regenerative Drugs Production Market Share of Top 5 Players Table CAGR of Major Market (2021-2027) Table CAGR in Terms of Production of Each Type (2026-2027) Table CAGR in Terms of Production of Each Application (2026-2027) Table Global Regenerative Drugs Sales (K Unit) by Type (2026-2027) Figure Global Regenerative Drugs Sales (K Unit) and Growth Rate (2026-2027) Figure Global Regenerative Drugs Sales Market Share (%) by Type (2019 -2020) Table Global Regenerative Drugs Sales Value (Million USD) by Type (2026-2027) Figure Global Regenerative Drugs Sales Value (Million USD) and Growth Rate (2026-2027) Figure Global Regenerative Drugs Sales Value Market Share (%) by Type (2019-2020) Table Global Regenerative Drugs Sales (K Unit) by Application (2026-2027) Table China Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table China Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table China Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure China Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table China Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table China Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table China Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure China Regenerative Drugs Sales (Unit) by Type (2026-2027) Table EU Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table EU Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table EU Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure EU Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table EU Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table EU Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table EU Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure EU Regenerative Drugs Sales (Unit) by Type (2026-2027) Table USA Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table USA Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table USA Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure USA Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table USA Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table USA Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table USA Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure USA Regenerative Drugs Sales (Unit) by Type (2026-2027) Table Japan Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table Japan Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table Japan Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure Japan Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table Japan Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table Japan Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table Japan Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure Japan Regenerative Drugs Sales (Unit) by Type (2026-2027) Table India Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table India Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table India Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure India Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table India Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table India Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table India Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure India Regenerative Drugs Sales (Unit) by Type (2026-2027) Table Southeast Asia Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table Southeast Asia Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table Southeast Asia Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure Southeast Asia Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table Southeast Asia Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table Southeast Asia Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table Southeast Asia Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure Southeast Asia Regenerative Drugs Sales (Unit) by Type (2026-2027) Table South America Regenerative Drugs Sales (K Unit) of Major Company (2016-2021) Table South America Regenerative Drugs Sales Market Share of Major Company (2016-2021) Table South America Regenerative Drugs Sales Value (Million USD) of Major Company (2016-2021) Figure South America Regenerative Drugs Sales Value (Million USD) and Growth Rate (2016-2021) Table South America Regenerative Drugs Sales Value Share of Major Company (2016-2021) Table South America Regenerative Drugs Price (USD/Unit), by Type (2019-2020) Table South America Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure South America Regenerative Drugs Sales (Unit) by Type (2026-2027) Figure Value Chain Structure of Regenerative Drugs Table Value Chain Table Key Suppliers of Raw Material/Components Table Key Downstream Customer in Each Application Field Table Industry News List of Regenerative Drugs Figure Cost Structure of Regenerative Drugs in 2020 Table Distributors/Traders List Table Regional Market Sales (K Unit) (2021-2027) Table Regional Market Sales Share (2021-2027) Figure Global Regenerative Drugs Sales (Unit), Growth Rate & Market Share (2021-2027) Table Regional Market Sales Value (Million USD) (2021-2027) Table Regional Market Sales Value Share (2021-2027) Figure Global Regenerative Drugs Sales Value (Million USD), Growth Rate & Market Share (2021-2027) Table Stryker Profiles Table Stryker Regenerative Drugs Product Introduction Table Stryker Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Stryker SWOT Analysis Table Zimmer Biomet Holdings Profiles Table Zimmer Biomet Holdings Regenerative Drugs Product Introduction Table Zimmer Biomet Holdings Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Zimmer Biomet Holdings SWOT Analysis Table Medtronic Profiles Table Medtronic Regenerative Drugs Product Introduction Table Medtronic Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Medtronic SWOT Analysis Table Athersys Profiles Table Athersys Regenerative Drugs Product Introduction Table Athersys Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Athersys SWOT Analysis Table STEMCELL Technologies Profiles Table STEMCELL Technologies Regenerative Drugs Product Introduction Table STEMCELL Technologies Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure STEMCELL Technologies SWOT Analysis Table Organogenesis Profiles Table Organogenesis Regenerative Drugs Product Introduction Table Organogenesis Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Organogenesis SWOT Analysis Table Integra Lifesciences Profiles Table Integra Lifesciences Regenerative Drugs Product Introduction Table Integra Lifesciences Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Integra Lifesciences SWOT Analysis Table Acelity Profiles Table Acelity Regenerative Drugs Product Introduction Table Acelity Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Acelity SWOT Analysis Table Isto Biologics Profiles Table Isto Biologics Regenerative Drugs Product Introduction Table Isto Biologics Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021) Figure Isto Biologics SWOT Analysis Table CryoLife Profiles Table CryoLife Regenerative Drugs Product Introduction Table CryoLife Regenerative Drugs Sales (Unit), Sales Value (Million USD), Price (USD/Unit) and Gross Profit (2016-2021)
